SCHEMBL4491434

SCHEMBL4491434

CN(C)CCN1CCSCC(NC(=O)O)C1=O

nearest known ligand 0.43

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ SRC P12931 12/20 0.42
▸ CASP1 P29466 5/20 0.41
▸ CASP8 Q14790 4/20 0.41
▸ KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14170730 0.84 KDM4E (0.36) SRCCASP1CASP8KDM4E
SCHEMBL4491437 0.78 SRC (0.40) SRCCASP1CASP8
SCHEMBL5220715 0.75 KDM4E (0.38) KDM4E
SCHEMBL4489025 0.74 SRC (0.58) SRCCASP1CASP8
Hydrochloric Acid SCHEMBL4483085 0.74 KDM4E (0.37) KDM4E
SCHEMBL5464431 0.74 KDM4E (0.32) KDM4E
SCHEMBL4487851 0.73 METAP1 (0.47) SRC
SCHEMBL4501161 0.72 SRC (0.49) SRCCASP1CASP8
SCHEMBL4494868 0.70 SRC (0.47) SRCCASP1CASP8
SCHEMBL14178723 0.70 SRC (0.37) SRCCASP1CASP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7550453-B2 Anticancer agents; colon cancer or hepatocellular carcinoma; analogs of bengamide where the caprolactam ring is changed and/or substituted e.g. N-(2-Methyl-3-oxo-2,3,4,5-tetrahydro-1H-2-benzazepin-4-yl)-(E)-(2R,3R,4S,5R)-3,4,5-trihydroxy-2-methoxy-8,8-dimethylnon-6-enamide AVENTIS PHARMA SA (FR) 2009-06-23 — — US disclosed
EP-1819679-A2 2-ALCOXY-3,4,5-TRIHYDROXY-ALKYLAMIDES, PREPARATION THEREOF, COMPOSITIONS CONTAINING THEM AND USE THEREOF Aventis Pharma S.A. (FR) 2007-08-22 — — EP disclosed
WO-2006056696-A2 2-ALCOXY-3,4,5-TRIHYDROXY-ALKYLAMIDES, PREPARATION THEREOF, COMPOSITIONS CONTAINING THEM AND USE THEREOF AVENTIS PHARMA S.A. (FR) 2006-06-01 — — WO disclosed
Send feedback